Your browser doesn't support javascript.
loading
S-1 monotherapy versus S-1 combination therapy in gemcitabine-refractory advanced pancreatic cancer: A meta-analysis (PRISMA) of randomized control trials.
Zhong, Sheng; Qie, Shuai; Yang, Liu; Yan, Qi; Ge, Linna; Wang, Zhongfeng.
Afiliação
  • Zhong S; Department of Neurosurgery, the First Hospital of Jilin University Clinical College, Jilin University, Changchun, China Department of the Radiotherapy, Hebei University Affiliated Hospital, Baoding Public Health College, Jilin University Basic Medical College, Qiqihar Medical University, Qiqihar Radiology Department, Jixi Mining General Hospital, Jixi Hepatopancreatobiliary Medicine Department, the First Hospital of Jilin University, Changchun, China.
Medicine (Baltimore) ; 96(30): e7611, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28746215
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Oxônico / Neoplasias Pancreáticas / Tegafur / Desoxicitidina / Antimetabólitos Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Oxônico / Neoplasias Pancreáticas / Tegafur / Desoxicitidina / Antimetabólitos Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article